IL94665A - N-Troaril-H9-Purine-6-Amines, their preparation process and pharmaceutical preparations containing them - Google Patents

N-Troaril-H9-Purine-6-Amines, their preparation process and pharmaceutical preparations containing them

Info

Publication number
IL94665A
IL94665A IL9466590A IL9466590A IL94665A IL 94665 A IL94665 A IL 94665A IL 9466590 A IL9466590 A IL 9466590A IL 9466590 A IL9466590 A IL 9466590A IL 94665 A IL94665 A IL 94665A
Authority
IL
Israel
Prior art keywords
compound
purin
amine
hydrogen
pyrrol
Prior art date
Application number
IL9466590A
Other languages
English (en)
Hebrew (he)
Other versions
IL94665A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL94665A0 publication Critical patent/IL94665A0/xx
Publication of IL94665A publication Critical patent/IL94665A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Television Signal Processing For Recording (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
IL9466590A 1989-06-09 1990-06-07 N-Troaril-H9-Purine-6-Amines, their preparation process and pharmaceutical preparations containing them IL94665A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/363,837 US5017578A (en) 1989-06-09 1989-06-09 N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents

Publications (2)

Publication Number Publication Date
IL94665A0 IL94665A0 (en) 1991-04-15
IL94665A true IL94665A (en) 1994-06-24

Family

ID=23431950

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9466590A IL94665A (en) 1989-06-09 1990-06-07 N-Troaril-H9-Purine-6-Amines, their preparation process and pharmaceutical preparations containing them

Country Status (21)

Country Link
US (1) US5017578A (fr)
EP (1) EP0402752B1 (fr)
JP (1) JPH06102663B2 (fr)
KR (2) KR100199524B1 (fr)
CN (1) CN1029968C (fr)
AT (1) ATE127807T1 (fr)
AU (1) AU636351B2 (fr)
CA (1) CA2018563C (fr)
DE (1) DE69022294T2 (fr)
DK (1) DK0402752T3 (fr)
ES (1) ES2078267T3 (fr)
FI (1) FI902850A0 (fr)
GR (1) GR3017743T3 (fr)
HU (1) HU207320B (fr)
IE (1) IE68433B1 (fr)
IL (1) IL94665A (fr)
MX (1) MX21088A (fr)
NO (1) NO902555L (fr)
NZ (1) NZ233970A (fr)
PT (1) PT94297B (fr)
ZA (1) ZA904443B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
JP3355237B2 (ja) * 1993-10-15 2002-12-09 呉羽化学工業株式会社 Ｎ−（置換アミノ）ピロール誘導体、その製造方法及び除草剤
SK146096A3 (en) * 1994-05-10 1997-07-09 Sandoz Ltd Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
EP1554572B1 (fr) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
CA2535620A1 (fr) * 2003-08-15 2005-02-24 Irm Llc Composes et compositions inhibiteurs de l'activite du recepteur tyrosine kinase
CN100447143C (zh) * 2003-08-15 2008-12-31 Irm责任有限公司 作为rtk抑制剂的6-取代的苯胺基嘌呤
EP3827747A1 (fr) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Système pharma-informatique
EP2063905B1 (fr) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104744470A (zh) * 2014-10-31 2015-07-01 合肥平光制药有限公司 一种茶碱的合成方法
US10653681B2 (en) 2016-03-16 2020-05-19 Recurium Ip Holdings, Llc Analgesic compounds
CN106632339B (zh) * 2016-12-16 2018-11-27 温州医科大学 一种6-取代-9h-嘌呤类衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016378A (en) * 1959-07-01 1962-01-09 Thomae Gmbh Dr K Amino-substituted purine derivatives
US3796700A (en) * 1970-06-30 1974-03-12 Takedo Chem Ind Ltd Adenosine derivatives and the production thereof
JPS4935635B1 (fr) * 1970-12-28 1974-09-25
US3936454A (en) * 1973-08-14 1976-02-03 Warner-Lambert Company 5-Amino-4-chloro-6-(substituted amino)-pyrimidines
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
EP0180614B1 (fr) * 1984-04-18 1990-03-07 Whitby Research Incorporated Derives d'adenosine n-6 substitues utilises comme vasodilatateurs cardiaques
US4657897A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
CA1254888A (fr) * 1984-10-26 1989-05-30 Bharat Trivedi N.sup.6-bicyclo-adenosines
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
US4780452A (en) * 1986-09-08 1988-10-25 Burroughs Wellcome Co. F-substituted-3-β-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
PT94297A (pt) 1991-02-08
NZ233970A (en) 1993-02-25
MX21088A (es) 1993-11-01
HU207320B (en) 1993-03-29
ES2078267T3 (es) 1995-12-16
CN1047866A (zh) 1990-12-19
JPH0324080A (ja) 1991-02-01
IE68433B1 (en) 1996-06-12
EP0402752A1 (fr) 1990-12-19
EP0402752B1 (fr) 1995-09-13
NO902555L (no) 1990-12-10
DK0402752T3 (da) 1996-01-15
CN1029968C (zh) 1995-10-11
DE69022294T2 (de) 1996-03-14
ZA904443B (en) 1991-03-27
IE902077L (en) 1990-12-09
IL94665A0 (en) 1991-04-15
JPH06102663B2 (ja) 1994-12-14
FI902850A0 (fi) 1990-06-07
ATE127807T1 (de) 1995-09-15
AU5691990A (en) 1990-12-13
GR3017743T3 (en) 1996-01-31
NO902555D0 (no) 1990-06-08
US5017578A (en) 1991-05-21
AU636351B2 (en) 1993-04-29
KR910000730A (ko) 1991-01-30
KR100199524B1 (ko) 1999-06-15
HUT54156A (en) 1991-01-28
PT94297B (pt) 1997-01-31
KR100210179B1 (ko) 1999-07-15
HU903768D0 (en) 1990-11-28
CA2018563A1 (fr) 1990-12-09
CA2018563C (fr) 2000-09-19
DE69022294D1 (de) 1995-10-19

Similar Documents

Publication Publication Date Title
EP0417584B1 (fr) 4-Pyrimidinamines et -pyrimidindiamines N-substituées, procédé pour leur préparation et leur utilisation comme médicaments
IL94665A (en) N-Troaril-H9-Purine-6-Amines, their preparation process and pharmaceutical preparations containing them
EP0303507B1 (fr) Dérivés d'indole
EP0656360B1 (fr) Derive d'ester carboxylique de trifluoromethylpyrroloindole et procede pour sa fabrication
US5736549A (en) Hypoxanthine and guanine compounds
WO2001087038A2 (fr) Derives $g(b)-carboline utiles en tant qu'inhibiteurs de la phosphodiesterase
AU2001261167A1 (en) Beta-carboline derivatives useful as inhibitors of phosphodiesterase
AU2008304417A1 (en) Polo-like kinase inhibitors
EP1448562B1 (fr) Derives tetracycliques substitues de pyrroloquinolone utiles en tant qu'inhibiteurs de phosphodiesterase
EP1109814B1 (fr) Pyrazolo 4,3-d]-pyrimidin-7-ones 5-heterocyclyle, servant au traitement des troubles de l'erection chez l'homme
CA2013087C (fr) Derives de carbonate d'eseroline, procede de preparation et utilisation comme medicaments
HU206872B (en) Process for producing condensed pyrazolo-3-oxo-propiono-nitril derivatives and pharmaceutical compositions containing them
EP0415103B1 (fr) 2,3-Dihydro-1-(pyridinylamino)-indoles, procédé pour leur préparation et leur utilisation comme médicaments
US5155098A (en) N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them
JPH02164881A (ja) 治療用ヌクレオシド化合物
TW201632526A (zh) 免疫疾病之預防及／或治療劑
EP0244352B1 (fr) Dérivés de pyrido[4,3-d]pyrimidine
JPH06247942A (ja) ピペラジン誘導体
AU2004201386B2 (en) 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
JPH02221271A (ja) デスアセチルホルスコリンの７―アリール―およびヘテロアリールエーテル
EP0560231A1 (fr) Dérivés de la pyrazolo(3,4-a)acridine comme analgésiques
EP0402807A2 (fr) 7H-Benzo (b)pyrazino(1,2-d)pyrrolo(3,2,1-jk)(1,4)benzodiazépines, leur procédé de préparation et leur utilisation comme médicaments
JPH01102077A (ja) ２，６‐メタノピロロ‐３‐ベンズアゾジン類
JPH05194518A (ja) ６−メルカプトプリン誘導体及びその製法
JPH0834786A (ja) トリフルオロメチルピロロインドール誘導体及びその製造方法

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
RH Patent void